This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Series
Menu

Jens Niewoehner, PhD
Senior Principal Scientist at Roche Pharmaceutical Research and Early Development
Speaker

Profile

Jens Niewoehner obtained his Ph.D. at the Max-Planck-Institute for Cell Biology in Martinsried close to Munich. Following a PostDoc at the Curie Institute in Paris, he worked for two small Biotech start-ups in the Munich area before joining Roche Pharmaceutical Research and Early Development (pRED) in 2006. With his group, he is developing cellular functional assay for biotherapeutics characterization and screening. Since several years, he is actively involved in driving the development of the Roche Brain Shuttle platform to enable brain uptake of large-molecule drugs.

At this event

Prev
Next
Andy Nixon
Biotherapeutics Molecule Discovery Vice President
Boehringer Ingelheim

See Jens at Antibody Engineering & Therapeutics Series